BDBM801009 US12590070, Compound 28::adamantan-1-carboxamide

SMILES CNC(=O)c1cccc(C)c1Nc1nc(Nc2ccc(NC(=O)[C@]34CC5CC(C3)[C@H](N3CC[C@H](NC(C)=O)C3)C(C5)C4)cc2OC)ncc1C(F)(F)F

InChI Key InChIKey=OZUJGDFIXGDFDQ-UHFFFAOYSA-N

Data  3 IC50

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 801009   

TargetFocal adhesion kinase 1(Human)
Samjin Pharmaceutical Co.

US Patent

LigandBDBM801009(adamantan-1-carboxamide | US12590070, Compound 28)Copy SMILESCopy InChI

Affinity DataIC50: 29nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sid

In Depth
Date in BDB:
8/10/2026
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetProtein-tyrosine kinase 2-beta(Human)
Samjin Pharmaceutical Co.

US Patent

LigandBDBM801009(adamantan-1-carboxamide | US12590070, Compound 28)Copy SMILESCopy InChI

Affinity DataIC50: 64.5nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair

Target InfoPDB
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sid

In Depth
Date in BDB:
8/10/2026
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetInsulin receptor(Human)
Samjin Pharmaceutical Co.

US Patent

LigandBDBM801009(adamantan-1-carboxamide | US12590070, Compound 28)Copy SMILESCopy InChI

Affinity DataIC50: 1.00E+4nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sid

In Depth
Date in BDB:
8/10/2026
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL